Total Payments
$30,719
2024 Payments
$4,443
Companies
40
Transactions
1,210
Medicare Patients
7,456
Medicare Billing
$8.7M
Payment Breakdown by Category
Food & Beverage$25,984 (84.6%)
Other$4,500 (14.6%)
Education$235.11 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,984 | 1,199 | 84.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,500 | 4 | 14.6% |
| Education | $235.11 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $7,929 | 166 | $0 (2024) |
| Amgen Inc. | $3,089 | 144 | $0 (2024) |
| PFIZER INC. | $2,857 | 143 | $0 (2024) |
| Janssen Biotech, Inc. | $2,490 | 131 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,320 | 132 | $0 (2024) |
| UCB, Inc. | $1,819 | 101 | $0 (2024) |
| Lilly USA, LLC | $1,479 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,244 | 65 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,015 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $995.38 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,443 | 171 | ABBVIE INC. ($648.97) |
| 2023 | $4,180 | 174 | Novartis Pharmaceuticals Corporation ($488.04) |
| 2022 | $2,622 | 140 | Novartis Pharmaceuticals Corporation ($369.88) |
| 2021 | $2,451 | 127 | AbbVie Inc. ($358.49) |
| 2020 | $2,425 | 123 | Amgen Inc. ($478.55) |
| 2019 | $3,407 | 166 | PFIZER INC. ($763.64) |
| 2018 | $5,959 | 176 | AbbVie, Inc. ($2,404) |
| 2017 | $5,232 | 133 | AbbVie, Inc. ($2,800) |
All Payment Transactions
1,210 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Immunology | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Immunology | ||||||
| 11/11/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Biosimilars | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/04/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/30/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $169.93 | General |
| Category: Rheumatology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,816 | 135,828 | $5.5M | $1.6M |
| 2022 | 31 | 2,234 | 206,249 | $7.5M | $2.7M |
| 2021 | 27 | 1,715 | 155,519 | $6.0M | $2.5M |
| 2020 | 32 | 1,691 | 82,960 | $4.3M | $1.9M |
Total Patients
7,456
Total Services
580,556
Medicare Billing
$8.7M
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 76 | 12,375 | $1.2M | $417,215 | 33.7% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 82 | 29,073 | $1.5M | $304,468 | 20.9% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 46 | 50,400 | $1.0M | $197,083 | 19.6% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 21 | 2,752 | $481,250 | $174,263 | 36.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 110 | 8,160 | $222,601 | $148,187 | 66.6% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 23 | 27,280 | $272,800 | $127,974 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 397 | 1,129 | $326,281 | $105,565 | 32.4% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 17 | 1,537 | $169,070 | $40,215 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 383 | $76,600 | $23,725 | 31.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 170 | 349 | $34,900 | $17,317 | 49.6% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 27 | 293 | $43,950 | $16,099 | 36.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 72 | 137 | $75,350 | $13,791 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 54 | 54 | $20,250 | $8,704 | 43.0% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 15 | 19 | $28,500 | $7,478 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 49 | $13,180 | $6,673 | 50.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 75 | 116 | $18,560 | $5,437 | 29.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 166 | 437 | $13,110 | $4,845 | 37.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 29 | 92 | $13,800 | $2,029 | 14.7% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 27 | 27 | $3,375 | $1,363 | 40.4% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 22 | 26 | $3,380 | $950.47 | 28.1% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 65 | 208 | $2,560 | $929.58 | 36.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 17 | 85 | $4,250 | $556.87 | 13.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 29 | 42 | $1,445 | $506.12 | 35.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 20 | 45 | $575.00 | $225.10 | 39.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 23 | 24 | $912.00 | $220.16 | 24.1% |
About Dr. Bradley Weitzner, MD
Dr. Bradley Weitzner, MD is a Rheumatology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598705188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Weitzner, MD has received a total of $30,719 in payments from pharmaceutical and medical device companies, with $4,443 received in 2024. These payments were reported across 1,210 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($25,984).
As a Medicare-enrolled provider, Weitzner has provided services to 7,456 Medicare beneficiaries, totaling 580,556 services with total Medicare billing of $8.7M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Sarasota, FL
- Active Since 06/08/2006
- Last Updated 10/26/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1598705188
Products in Payments
- XELJANZ (Drug) $2,437
- Cimzia (Drug) $1,591
- Enbrel (Biological) $1,529
- RINVOQ (Biological) $1,423
- COSENTYX (Biological) $1,383
- TALTZ (Drug) $1,343
- BENLYSTA (Biological) $1,222
- TREMFYA (Drug) $1,074
- SIMPONI ARIA (Biological) $1,057
- Humira (Biological) $984.72
- COSENTYX (Drug) $885.11
- SAPHNELO (Biological) $804.28
- ORENCIA (Biological) $725.58
- Otezla (Drug) $617.71
- Tymlos (Biological) $446.73
- Actemra (Biological) $417.99
- LUPKYNIS (Drug) $412.23
- EVENITY (Biological) $394.72
- KRYSTEXXA (Biological) $390.55
- REMICADE (Biological) $389.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Sarasota
Dr. Jeffrey Kaine, Md, MD
Rheumatology — Payments: $705,178
Rheumatology $705,178
Kaitlin Lima, M.d, M.D
Rheumatology — Payments: $90,065
Rheumatology $90,065
Dr. Alissa Chandler, Md, MD
Rheumatology — Payments: $37,158
Rheumatology $37,158
Dr. Jaishree Manohar, M.d, M.D
Rheumatology — Payments: $29,725
Rheumatology $29,725
Sampath Manickam, M.d, M.D
Rheumatology — Payments: $26,702
Rheumatology $26,702
Dr. Robert Ikeman, Md, MD
Rheumatology — Payments: $25,392
Rheumatology $25,392